Statin use is associated with reduced mortality after respiratory viral infection

BACKGROUND: Several studies suggest that statins, besides reducing cardiovascular disease, have anti-inflammatory properties which might provide a benefit in downregulating the immune response after a respiratory viral infection (RVI) and, hence, decreasing subsequent complications. We aim to analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco-Peláez, Juan Antonio, Esteban-Lucia, Laura, Zambrano Chacón, María de los Ángeles, Pello-Lázaro, Ana María, Venegas Rodriguez, Ana María, Nieto Roca, Luis, García-Talavera, Camila Sofia, Kallmeyer Mayor, Andrea, Villar Alvarez, Felipe, Fernandez Roblas, Ricardo, Gonzalez-Lorenzo, Oscar, Tuñón, José, Ibañez, Borja, Aceña, Alvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861028/
https://www.ncbi.nlm.nih.gov/pubmed/33569498
http://dx.doi.org/10.1183/23120541.00365-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861028/
https://www.ncbi.nlm.nih.gov/pubmed/33569498
http://dx.doi.org/10.1183/23120541.00365-2020

Ejemplares similares